Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase
Journal of Biological Chemistry · 2023-03 · 299 (3) · 103002
DOI: 10.1016/j.jbc.2023.103002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-03. Verfasst von Naomoto Harada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discovery and Preclinical Research Division, Taiho Pharmaceutical Co Ltd, Tsukuba, Ibaraki, Japan. Electronic address: nm-harada@taiho.co.jp. Hauptthemen laut MEDLINE: Mitochondrial Encephalomyopathies, Mitochondrial Myopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Plasma thymidine levels in rodents are higher than in other mammals including humans, possibly due to a different pattern and lower level of thymidine phosphorylase expression. Here, we generated a novel knock-in (KI) mouse line with high systemic expression of human thymidine phosphorylase to investigate this difference in nucleotide metabolism in rodents. The KI mice showed growth retardation around weaning and died by 4 weeks of age with a decrease in plasma thymidine level compared with the litter-control WT mice. These phenotypes were completely or partially rescued by administration of the thymidine phosphorylase inhibitor 5-chloro-6-(2-iminopyrrolidin-1-yl) methyl-2,4(1H,3H)-pyrimidinedione hydrochloride or thymidine, respectively. Interestingly, when thymidine phosphorylase inhibitor administration was discontinued in adult animals, KI mice showed deteriorated grip strength and locomotor activity, decreased bodyweight, and subsequent hind-limb paralysis. Upon histological analyses, we observed axonal degeneration in the spinal cord, muscular atrophy with morphologically abnormal mitochondria in quadriceps, retinal degeneration, and abnormality in the exocrine pancreas. Moreover, we detected mitochondrial DNA depletion in multiple tissues of KI mice. These results indicate that the KI mouse represents a new animal model for mitochondrial diseases and should be applicable for the study of differences in nucleotide metabolism between humans and mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discovery and Preclinical Research Division, Taiho Pharmaceutical Co Ltd, Tsukuba, Ibaraki, Japan. Electronic address: nm-harada@taiho.co.jp.
- Discovery and Preclinical Research Division, Taiho Pharmaceutical Co Ltd, Tsukuba, Ibaraki, Japan.
Zitieren
APA
Harada, N., Nagasaki, H., Yamamoto, H., Matsubara, K., Suzuki, T., Gomori, A., Yokogawa, T., Matsuo, K., & Miyadera, K. (2023). Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase. Journal of Biological Chemistry, 299(3), 103002. https://doi.org/10.1016/j.jbc.2023.103002
Vancouver
Harada N, Nagasaki H, Yamamoto H, Matsubara K, Suzuki T, Gomori A, et al. Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase. Journal of Biological Chemistry. 2023;299(3):103002. doi:10.1016/j.jbc.2023.103002
BibTeX
@article{Harada2023,
author = {Harada, Naomoto and Nagasaki, Haruka and Yamamoto, Hiromi and Matsubara, Kenji and Suzuki, Takamasa and Gomori, Akira and Yokogawa, Tatsushi and Matsuo, Kenichi and Miyadera, Kazutaka},
title = {Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {3},
pages = {103002},
doi = {10.1016/j.jbc.2023.103002}
}
EUVIMED